Taste evaluation test for DNW-14012-001
Not Applicable
Completed
- Conditions
- Chemotherapy-and/or radiation-induced oral mucositis
- Registration Number
- JPRN-UMIN000029929
- Lead Sponsor
- Pharmaspur Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 6
Inclusion Criteria
Not provided
Exclusion Criteria
Subjects using medical products Subjects who could start having allergic symptom in relation to test products Subjects with a disease of the oral mucous membrane (including a wound in the mouth) or subjects under dental treatment Subjects judged inappropriate for the study by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Measurement of threshold of saltiness by test paper (SALSAVE)
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms does DNW-14012-001 target for treating chemotherapy-and/or radiation-induced oral mucositis?
How does DNW-14012-0001 compare to standard-of-care treatments for oral mucositis in terms of efficacy and patient outcomes?
Are there specific biomarkers that can predict patient response to DNW-14012-001 in the context of oral mucositis?
What are the known or potential adverse events associated with DNW-14012-001 and how can they be managed in clinical practice?
What related compounds or combination therapies are being explored by Pharmaspur Inc. for the treatment of chemotherapy-and/or radiation-induced oral mucositis?